People | 14 April 2025
Dabur appoints Sriram Padmanabhan as Head of Health Care Business
Padmanabhan brings over two decades of extensive experience in FMCG sector
Padmanabhan brings over two decades of extensive experience in FMCG sector
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Peter Bains has over three decades of experience in the biotech and pharmaceutical industry
He has over 23 years of experience across sectors
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
